Superhydrophobic and Conductive Foams with Antifouling and Oil–Water Separation Properties
Source abstract
Abstract
Hybrid organic–inorganic materials are attracting enormous interest in materials science due to the combination of multiple advantageous properties of both organic and inorganic components. Taking advantage of a simple, scalable, solvent-free hard-sacrificial method, we report the successful fabrication of three-dimensional hybrid porous foams by integrating two types of fillers into a poly(dimethylsiloxane) (PDMS) framework. These fillers consist of hydrophobic electrically conductive graphene (GR) nanoplatelets and hydrophobic bactericidal copper (Cu) microparticles. The fillers were utilized to create the hierarchical rough structure with low-surface-energy properties on the PDMS foam surfaces, leading to remarkable superhydrophobicity/superoleophilicity with contact angles of 158 and 0° for water and oil, respectively. The three-dimensional interconnected porous foam structures facilitated high oil adsorption capacity and excellent reusability as well as highly efficient oil/organic solvent–water separation in turbulent, corrosive, and saline environments. Moreover, the introduction of the fillers led to a significant improvement in the electrical conductivity and biofouling resistance (vs whole blood, fibrinogen, platelet cells, and Escherichia coli ) of the foams. We envision that the developed composite strategy will pave a facile, scalable, and effective way for fabricating novel multifunctional hybrid materials with ideal properties that may find potential use in a broad range of biomedical, energy, and environmental applications.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Surface Modification and Superhydrophobicity · Advanced Sensor and Energy Harvesting Materials · Electrospun Nanofibers in Biomedical Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
School of Chemical, Materials and Biomedical Engineering, College of Engineering, University of Georgia, Athens, Georgia 30602, United States
Pharmaceutical and Biomedical Sciences Department, College of Pharmacy, University of Georgia, Athens, Georgia 30602, United States
Funding
National Heart, Lung, and Blood Institute · National Science Foundation
References (69)
Show source-provided references
1. 10.1016/J.APSUSC.2011.11.04510.1016/J.APSUSC.2011.11.045 ↗
2. 10.1007/s00425005009610.1007/s004250050096 ↗
3. 10.1126/science.aaa094610.1126/science.aaa0946 ↗
4. 10.1002/admi.20150012410.1002/admi.201500124 ↗
5. 10.1002/smll.20140051610.1002/smll.201400516 ↗
6. 10.1021/acsnano.5b0681610.1021/acsnano.5b06816 ↗
7. 10.1016/J.APSUSC.2016.01.20810.1016/J.APSUSC.2016.01.208 ↗
8. 10.1002/adfm.20110109010.1002/adfm.201101090 ↗
9. 10.1021/acs.iecr.0c0127610.1021/acs.iecr.0c01276 ↗
10. 10.1016/j.seppur.2019.11630810.1016/j.seppur.2019.116308 ↗
11. 10.1016/j.cej.2017.12.13510.1016/j.cej.2017.12.135 ↗
12. 10.1038/s41598-017-09912-910.1038/s41598-017-09912-9 ↗
13. 10.1016/j.jhazmat.2016.11.00410.1016/j.jhazmat.2016.11.004 ↗
14. 10.1016/j.apsusc.2015.11.21510.1016/j.apsusc.2015.11.215 ↗
15. 10.1021/acs.langmuir.1c0064010.1021/acs.langmuir.1c00640 ↗
16. 10.1021/jacs.6b0226210.1021/jacs.6b02262 ↗
17. 10.1016/j.cej.2017.07.08610.1016/j.cej.2017.07.086 ↗
18. 10.1016/j.polymertesting.2020.10642910.1016/j.polymertesting.2020.106429 ↗
19. 10.1021/la00092a02610.1021/la00092a026 ↗
20. 10.1016/j.colsurfa.2022.12849010.1016/j.colsurfa.2022.128490 ↗
21. 10.1016/j.reactfunctpolym.2019.05.00210.1016/j.reactfunctpolym.2019.05.002 ↗
22. 10.1002/term.241410.1002/term.2414 ↗
23. 10.1097/00001432-200404000-0000410.1097/00001432-200404000-00004 ↗
24. 10.1016/j.cej.2019.12199910.1016/j.cej.2019.121999 ↗
25. 10.1016/j.ajps.2022.01.00110.1016/j.ajps.2022.01.001 ↗
26. 10.1016/j.cej.2019.05.04310.1016/j.cej.2019.05.043 ↗
27. 10.1016/j.carbpol.2018.12.05010.1016/j.carbpol.2018.12.050 ↗
28. 10.1016/j.msec.2019.10974110.1016/j.msec.2019.109741 ↗
29. 10.1016/j.msec.2019.10989310.1016/j.msec.2019.109893 ↗
30. 10.1021/acsami.8b1974610.1021/acsami.8b19746 ↗
31. 10.1038/s41467-019-13512-810.1038/s41467-019-13512-8 ↗
32. 10.3390/NANO1216276210.3390/NANO12162762 ↗
33. 10.1021/acsami.6b1119610.1021/acsami.6b11196 ↗
34. 10.1021/acsomega.1c0095210.1021/acsomega.1c00952 ↗
35. 10.1155/2013/28468310.1155/2013/284683 ↗
36. 10.1007/s10544-005-6070-210.1007/s10544-005-6070-2 ↗
37. 10.1007/s13213-010-0015-610.1007/s13213-010-0015-6 ↗
38. 10.1016/j.biomaterials.2009.10.00810.1016/j.biomaterials.2009.10.008 ↗
39. ISO. ISO 10993-5:2009: Biological Evaluation of Medical Devices─Part 5: Tests for Cytotoxicity: In Vitro Methods, 3rd ed. International Organization for Standardization, 2009.
40. 10.1021/acsomega.9b0399410.1021/acsomega.9b03994 ↗
41. 10.1021/am201352w10.1021/am201352w ↗
42. 10.1002/app.4844910.1002/app.48449 ↗
43. 10.1038/s41545-019-0034-110.1038/s41545-019-0034-1 ↗
44. 10.1021/acsanm.2c0241810.1021/acsanm.2c02418 ↗
45. 10.1039/c7ta02202f10.1039/c7ta02202f ↗
46. 10.1016/j.cej.2020.12749310.1016/j.cej.2020.127493 ↗
47. 10.1021/acsmacrolett.7b0087910.1021/acsmacrolett.7b00879 ↗
48. 10.1016/j.heliyon.2018.e0106710.1016/j.heliyon.2018.e01067 ↗
49. 10.1002/adfm.20190938910.1002/adfm.201909389 ↗
50. 10.1016/j.colsurfa.2021.12704110.1016/j.colsurfa.2021.127041 ↗
51. 10.1016/j.jcis.2021.09.18310.1016/j.jcis.2021.09.183 ↗
52. 10.1039/c6sc01150k10.1039/c6sc01150k ↗
53. 10.1021/acsami.0c1309810.1021/acsami.0c13098 ↗
54. 10.1111/j.1365-2672.2000.tb05338.x10.1111/j.1365-2672.2000.tb05338.x ↗
55. 10.1134/S199507801303006310.1134/S1995078013030063 ↗
56. 10.1016/j.msec.2014.03.01710.1016/j.msec.2014.03.017 ↗
57. 10.1002/adma.20190800810.1002/adma.201908008 ↗
58. Viamontes L. · Ostomy Wound Manage. · 2003 · 49 · 48
59. Briggs M. · Nurs. Times · 2004 · 100 · 56
60. 10.3238/arztebl.2008.023910.3238/arztebl.2008.0239 ↗
61. 10.1039/B711944E10.1039/B711944E ↗
62. ISO. ISO 10993-4: Biological Evaluation of Medical Devices ─ Part 4: Selection of Tests for Interactions with Blood; International Organization for Standardization, 2017.
63. 10.1021/acsabm.0c0069510.1021/acsabm.0c00695 ↗
64. 10.1021/acsami.0c1990410.1021/acsami.0c19904 ↗
65. 10.1039/c8nh00021b10.1039/c8nh00021b ↗
66. 10.1039/C8NR00004B10.1039/C8NR00004B ↗
67. 10.1002/smll.20190282010.1002/smll.201902820 ↗
68. 10.1115/1.403723810.1115/1.4037238 ↗
69. 10.1007/s12274-020-3148-310.1007/s12274-020-3148-3 ↗